Back

Polygenic risk score for hypertrophic cardiomyopathy predicts population disease risk, penetrance in sarcomeric rare variant carriers and survival in cases

26 August 2023 (13:00 - 13:15)
Organised by: Logo
Congress Presentation Part of: Young Investigator Awards Session in Heart Failure Epidemiology, Prognosis, Outcome Open Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Sean Zheng

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

2 More presentations in this session

Presentation thumbnail
DNA methylation profiling of circulating CD4+ T cells and network analysis reveal that JUNB, SETD7, and MEF2D genes predict patients with heart failure preserved vs. reduced ejection fraction
Doctor G. Benincasa (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Heart failure medical therapy and outcomes in patients undergoing transcatheter mitral valve repair for secondary mitral regurgitation: a TVT Registry analysis across 449 US centers
Doctor A. Varshney (Palo Alto, US)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Awards Session in Heart Failure
Video

The Event

Event poster

ESC Congress 2023

26 August 2023 13:00 CET
You may be interested in
thumbnail
Congress Presentation
How should genetics inform the treatment of hypertrophic cardiomyopathies?
thumbnail
Congress Session
Translating genome-wide association studies (GWAS) into diagnostic and therapeutic targets for cardiovascular disease
thumbnail
Congress Session
Methods toolbox: genetics

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources